TokenPost topic

Hemab Therapeutics

1 TokenPost story is tagged Hemab Therapeutics. The newest appear first.

Latest Hemab Therapeutics stories

• Hemab Records $0.58 Loss Per Share in Third Quarter of 2026

  Net loss rose to $27.3 million from $17.1 million a year earlier as operating and research expenses increased.

  Nov 11, 2026, 7:33 AM EST · Business